Patent · US Active

Compounds as nuclear transport modulators and uses thereof

US12234226B2 · kind B2 · utility

0Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 18, 2023
Grant dateFeb 25, 2025
Priority date
Expiry dateMay 18, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D419/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Nuclear transport modulators are disclosed. The compounds can inhibit nuclear transporters such as the exportin-1 transporter. The compounds and pharmaceutical compositions comprising the compounds can be used to treat neurological diseases and cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.